Sanofi SA (SASY)

Paris
Currency in EUR
84.16
+0.84(+1.01%)
Closed·
SASY Scorecard
Full Analysis
Has raised its dividend for 26 consecutive years
High dividend Yield
Fair Value
Day's Range
83.6184.30
52 wk Range
81.50110.88
Key Statistics
Edit
Prev. Close
83.32
Open
83.75
Day's Range
83.61-84.3
52 wk Range
81.5-110.88
Volume
2.11M
Average Volume (3m)
2.17M
1-Year Change
-9.46%
Book Value / Share
63.32
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SASY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
112.64
Upside
+33.84%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period

Sanofi SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, yellow fever, and rabies vaccines. In addition, the company has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as an strategic alliance with the Department of Health – Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Employees
82878
Market
France

Compare SASY to Peers and Sector

Metrics to compare
SASY
Peers
Sector
Relationship
P/E Ratio
16.3x12.7x−0.5x
PEG Ratio
0.410.090.00
Price/Book
1.3x1.7x2.6x
Price / LTM Sales
2.2x2.1x3.1x
Upside (Analyst Target)
38.0%11.8%45.7%
Fair Value Upside
Unlock10.4%5.7%Unlock

Analyst Ratings

17 Buy
6 Hold
0 Sell
Ratings:
23 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 112.64
(+33.84% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.98%
Dividend Yield
4.70%
Annualised payout
3.92
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
1.38 / 1.69
Revenue / Forecast
10.61B / 10.23B
EPS Revisions
Last 90 days

Sanofi (SASY) Income Statement & Profits

People Also Watch

714.01
MCK
-1.82%
50.62
SOGN
-2.65%
1,845.500
RHMG
-0.81%
382.25
OREP
+2.11%
246.30
TCFP
-0.65%

FAQ

What Is the Sanofi (SASY) Share Price Today?

The live Sanofi share price today is 84.16.

What Stock Exchange Does Sanofi (SASY) Trade On?

Sanofi is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Ticker (Stock Symbol) for Sanofi?

The stock symbol (also called a 'ticker') for Sanofi is "SASY."

Does Sanofi Pay Dividends? What’s The Current SASY Dividend Yield?

Yes, SASY Pays Dividends to its Shareholders. The current Sanofi dividend yield is 4.7%.

What Is the Current Sanofi Market Cap?

As of today, Sanofi market capitalisation is 102.59B.

What Is Sanofi's (SASY) Earnings Per Share (TTM)?

The Sanofi EPS 4.98 (Trailing Twelve Months).

When Is the Next Sanofi Earnings Date?

Sanofi's next earnings report will be released on 30 Jul 2025.

Is SASY a Buy or Sell From a Technical Analyst Perspective?

Based on today's Sanofi moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Sanofi Stock Split?

Sanofi has split 0 times. (See the SASY stock split history page for full effective split date and price information.)

How Many Employees Does Sanofi Have?

Sanofi currently has 82878 employees.

What is the current trading status of Sanofi (SASY)?

As of 10 Jul 2025, Sanofi (SASY) is trading at a price of 84.16, with a previous close of 83.32. The stock has fluctuated within a day range of 83.61 to 84.30, while its 52-week range spans from 81.50 to 110.88.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.